Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-10

FDA Approved: TRAVOPROST — Original Application (Apotex Corp.)

View source ↗

Summary

The FDA approved Apotex Corp.'s original application for Travoprost, a generic eye drop used to lower intraocular pressure in glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Travoprost (Travoprost (isomer-free))

Snippet

ORIG AP for TRAVOPROST (TRAVOPROST)